Echoiq Limited has released a press release.
Groundbreaking study results for Heart Failure AI solution
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from EchoIQ
- Strategic Integration Partnership Agreement with ScImage Inc
- Validation of EIQ AI at Leading Scientific Conference
- Investor Presentation
- Echo IQ Commences New Heart Failure Clinical Study Using AI
- US FDA Application Lodged
Later from EchoIQ
- Echo IQ Raises $7.1 million
- Major Milestone Achieved with FDA Clearance for EchoSolv AS
- US Based CEO Appointed to Execute Commercialisation Strategy
- EIQ signs integration agreement with Flagship US Hospital
- S&P DJI Announces December 2024 Quarterly Rebalance
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ